Samuel G. Siris

6.8k total citations
119 papers, 4.1k citations indexed

About

Samuel G. Siris is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Samuel G. Siris has authored 119 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Psychiatry and Mental health, 36 papers in Clinical Psychology and 26 papers in Pharmacology. Recurrent topics in Samuel G. Siris's work include Schizophrenia research and treatment (67 papers), Treatment of Major Depression (26 papers) and Mental Health and Psychiatry (26 papers). Samuel G. Siris is often cited by papers focused on Schizophrenia research and treatment (67 papers), Treatment of Major Depression (26 papers) and Mental Health and Psychiatry (26 papers). Samuel G. Siris collaborates with scholars based in United States, Spain and United Kingdom. Samuel G. Siris's co-authors include Franklin R. Schneier, Paul C. Bermanzohn, John P. Docherty, Stephen R. Marder, Daniël P. van Kammen, Raphael J. Braga, José Alvir, Simcha Pollack, Miranda Chakos and David Mayerhoff and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Trends in Neurosciences.

In The Last Decade

Samuel G. Siris

116 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel G. Siris United States 32 3.2k 1.4k 783 761 649 119 4.1k
Martin Hambrecht Germany 20 2.1k 0.7× 919 0.6× 827 1.1× 282 0.4× 376 0.6× 44 2.7k
Peter Dingemans Netherlands 42 3.3k 1.1× 1.7k 1.2× 1.1k 1.5× 246 0.3× 725 1.1× 102 4.4k
Filippo Bogetto Italy 42 2.0k 0.6× 2.8k 2.0× 318 0.4× 435 0.6× 1.0k 1.6× 187 4.8k
Bruce Pfohl United States 34 1.6k 0.5× 3.4k 2.4× 1.1k 1.4× 529 0.7× 652 1.0× 87 4.8k
Douglas W Heinrichs United States 15 4.1k 1.3× 1.4k 0.9× 1.7k 2.2× 282 0.4× 748 1.2× 24 4.6k
Somaia Mohamed United States 27 1.8k 0.6× 966 0.7× 493 0.6× 338 0.4× 312 0.5× 77 2.9k
Cristòbal Gastó Spain 47 3.0k 1.0× 1.5k 1.0× 208 0.3× 1.1k 1.4× 895 1.4× 128 5.8k
Lakshmi N.P. Voruganti Canada 26 1.9k 0.6× 1.0k 0.7× 450 0.6× 282 0.4× 280 0.4× 34 2.5k
David Mayerhoff United States 14 2.9k 0.9× 1.1k 0.8× 1.2k 1.5× 228 0.3× 312 0.5× 35 3.3k
John Kasckow United States 33 1.1k 0.4× 1.1k 0.7× 219 0.3× 374 0.5× 405 0.6× 105 3.8k

Countries citing papers authored by Samuel G. Siris

Since Specialization
Citations

This map shows the geographic impact of Samuel G. Siris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel G. Siris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel G. Siris more than expected).

Fields of papers citing papers by Samuel G. Siris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel G. Siris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel G. Siris. The network helps show where Samuel G. Siris may publish in the future.

Co-authorship network of co-authors of Samuel G. Siris

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel G. Siris. A scholar is included among the top collaborators of Samuel G. Siris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel G. Siris. Samuel G. Siris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rolin, Stephanie A., Lisa B. Dixon, David A. Adler, et al.. (2017). Why We Need to Enhance Suicide Postvention. The Journal of Nervous and Mental Disease. 205(7). 507–511. 26 indexed citations
2.
Acosta, Francisco J., Yolanda Ramallo‐Fariña, & Samuel G. Siris. (2013). Should full adherence be a necessary goal in schizophrenia? Full versus non-full adherence to antipsychotic treatment. Comprehensive Psychiatry. 55(1). 33–39. 12 indexed citations
3.
DeRosse, Pamela, Katherine E. Burdick, Todd Lencz, Samuel G. Siris, & Anil K. Malhotra. (2013). Empirical Support for DSM-IV Schizoaffective Disorder: Clinical and Cognitive Validators from a Large Patient Sample. PLoS ONE. 8(5). e63734–e63734. 5 indexed citations
4.
Adler, David A., Lisa B. Dixon, Beth Goldman, et al.. (2011). The Psychiatric Note in the Era of Electronic Communication. The Journal of Nervous and Mental Disease. 199(4). 212–213. 3 indexed citations
5.
Sim, Kang, Yiong Huak Chan, Siow Ann Chong, & Samuel G. Siris. (2007). A 24-Month Prospective Outcome Study of First-Episode Schizophrenia and Schizoaffective Disorder Within an Early Psychosis Intervention Program. The Journal of Clinical Psychiatry. 68(9). 1368–1376. 14 indexed citations
6.
Dixon, Lisa B., David A. Adler, Rebecca Dulit, et al.. (2007). Best Practices: Psychiatrists and Primary Caring: What Are Our Boundaries of Responsibility?. Psychiatric Services. 58(5). 600–602. 14 indexed citations
7.
Acosta, Francisco J., et al.. (2006). Are there subtypes of suicidal schizophrenia? A prospective study. Schizophrenia Research. 86(1-3). 215–220. 23 indexed citations
8.
Kinon, Bruce J., Ilya Lipkovich, SJ Edwards, et al.. (2006). A 24-Week Randomized Study of Olanzapine Versus Ziprasidone in the Treatment of Schizophrenia or Schizoaffective Disorder in Patients with Prominent Depressive Symptoms. Journal of Clinical Psychopharmacology. 26(2). 157–162. 74 indexed citations
9.
Siris, Samuel G. & Paul C. Bermanzohn. (2003). Two Models of Psychiatric Rehabilitation: A Need for Clarity and Integration. Journal of Psychiatric Practice. 9(2). 171–175. 3 indexed citations
10.
Addington, Donald, Jean‐Michel Azorin, Ian R. H. Falloon, et al.. (2002). Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatrica Scandinavica. 105(3). 189–195. 42 indexed citations
11.
Siris, Samuel G., Donald Addington, Jean‐Michel Azorin, et al.. (2001). Depression in schizophrenia: recognition and management in the USA. Schizophrenia Research. 47(2-3). 185–197. 108 indexed citations
12.
Siris, Samuel G.. (2001). Suicide and schizophrenia. Journal of Psychopharmacology. 15(2). 127–135. 288 indexed citations
13.
Bermanzohn, Paul C., et al.. (2000). At Issue: Hierarchical Diagnosis in Chronic Schizophrenia: A Clinical Study of Co-occurring Syndromes. Schizophrenia Bulletin. 26(3). 517–525. 119 indexed citations
14.
Siris, Samuel G.. (2000). Depression in Schizophrenia: Perspective in the Era of “Atypical” Antipsychotic Agents. American Journal of Psychiatry. 157(9). 1379–1389. 319 indexed citations
15.
Siris, Samuel G., et al.. (1996). Adjunctive Loxapine in a Clozapine-Resistant Cohort of Schizophrenic Patients. Annals of Clinical Psychiatry. 8(4). 193–197. 45 indexed citations
16.
Bermanzohn, Paul C. & Samuel G. Siris. (1992). Akinesia: A syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia. Comprehensive Psychiatry. 33(4). 221–232. 85 indexed citations
17.
Siris, Samuel G.. (1991). Diagnosis of Secondary Depression in Schizophrenia: Implications for DSM-IV. Schizophrenia Bulletin. 17(1). 75–98. 174 indexed citations
18.
Gingerich, Susan, et al.. (1990). Patients' and Caregivers' Adaptation to Improvement in Schizophrenia. Psychiatric Services. 41(5). 541–544. 9 indexed citations
19.
Siris, Samuel G., et al.. (1989). Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression. Comprehensive Psychiatry. 30(6). 483–488. 1 indexed citations
20.
Siris, Samuel G., et al.. (1988). Histories of substance abuse in patients with postpsychotic depressions. Comprehensive Psychiatry. 29(6). 550–557. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Hambrecht Breakdown of academic impact, for papers by Peter Dingemans Breakdown of academic impact, for papers by Filippo Bogetto Breakdown of academic impact, for papers by Bruce Pfohl Breakdown of academic impact, for papers by Douglas W Heinrichs Breakdown of academic impact, for papers by Somaia Mohamed Breakdown of academic impact, for papers by Cristòbal Gastó Breakdown of academic impact, for papers by Lakshmi N.P. Voruganti Breakdown of academic impact, for papers by David Mayerhoff Breakdown of academic impact, for papers by John Kasckow
Rankless by CCL
2026